BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC157 Legal? WADA, FDA Status, and What You Need to Know The Pharmacology of Longevity: Peptide Edition (Part 1)